Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of $1.14B and trades at $17.50. The 52-week range is 3.5-25.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -38, Earnings Per Share (EPS) of $-0.46, annual revenue of $123.67M.
The stock has a beta of 1.64, operates in the Healthcare sector.
